Swiss National Bank Intercept Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$140 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$9.99 - $18.71 $18,981 - $35,549	1,900 Added 2.5%	77,900 $1.44 Million
Q1 2023 May 10, 2023	SELL	$12.53 - $21.71 $53,879 - $93,353	-4,300 Reduced 5.35%	76,000 $1.02 Million
Q4 2022 Feb 08, 2023	BUY	$11.61 - $16.11 $286,767 - $397,917	24,700 Added 44.42%	80,300 $993,000
Q2 2022 Aug 09, 2022	SELL	$11.23 - $19.59 $42,674 - $74,442	-3,800 Reduced 6.4%	55,600 $768,000
Q1 2022 May 09, 2022	SELL	$13.37 - $17.79 $33,425 - $44,475	-2,500 Reduced 4.04%	59,400 $966,000

Q2 2021 Aug 06, 2021	BUY	$15.46 - $24.5 $34,012 - $53,900	2,200 Added 3.69%	61,900 $1.24 Million
Q3 2020 Nov 09, 2020	BUY	$39.09 - $53.44 $39,090 - $53,440	1,000 Added 1.7%	59,700 $2.48 Million
Q2 2020 Aug 05, 2020	BUY	$46.7 - $92.04 $368,930 - $727,116	7,900 Added 15.55%	58,700 $2.81 Million
Q1 2020 May 08, 2020	BUY	$48.35 - $118.68 $33,845 - $83,076	700 Added 1.4%	50,800 $3.2 Million
Q4 2019 Feb 06, 2020	BUY	$57.36 - $124.1 $97,512 - $210,970	1,700 Added 3.51%	50,100 $6.21 Million
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $252,367 - $345,978	4,300 Added 9.75%	48,400 $3.21 Million
Q2 2019 Aug 02, 2019	BUY	$77.77 - $120.68 $482,174 - $748,216	6,200 Added 16.36%	44,100 $3.51 Million
Q1 2019 May 10, 2019	BUY	$91.83 - $120.68 $119,379 - $156,884	1,300 Added 3.55%	37,900 $4.24 Million
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $42,895 - $63,230	500 Added 1.39%	36,600 $3.69 Million
Q3 2018 Nov 08, 2018	BUY	$88.49 - $127.55 $70,792 - $102,040	800 Added 2.27%	36,100 $4.56 Million
Q2 2018 Aug 09, 2018	BUY	$60.0 - $85.67 $288,000 - $411,216	4,800 Added 15.74%	35,300 $2.96 Million
Q1 2018 May 04, 2018	BUY	$52.72 - $67.25 $68,536 - $87,425	1,300 Added 4.45%	30,500 $1.88 Million
Q3 2017 Nov 03, 2017	BUY	$57.01 - $118.75 $1.66 Million - $3.47 Million	29,200	29,200 $1.7 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account